Luminal B Breast Cancer clinical trials

Explore recruiting luminal b breast cancer clinical trials.

Recruiting luminal b breast cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Luminal B Breast Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Neo-adjuvant chemotherapy combined with Stereotactic Body Radiotherapy to the primary tumour +/- durvalumab (MEDI4736), +/- oleclumab (MEDI9447) in luminal B breast cancer: a phase ll randomised trial

Belgium, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Luminal B Breast Cancer trials by city

Luminal B Breast Cancer in Toronto Luminal B Breast Cancer in Vancouver Luminal B Breast Cancer in Montreal Luminal B Breast Cancer in Calgary Luminal B Breast Cancer in Edmonton Luminal B Breast Cancer in Ottawa Luminal B Breast Cancer in Winnipeg Luminal B Breast Cancer in Quebec City Luminal B Breast Cancer in Hamilton Luminal B Breast Cancer in Kitchener Luminal B Breast Cancer in London Luminal B Breast Cancer in Halifax Luminal B Breast Cancer in New York Luminal B Breast Cancer in Los Angeles Luminal B Breast Cancer in Chicago Luminal B Breast Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease